Skyler L Kanegi, Niushen Zhang, Cynthia E. Armand, Rashmi B Halker Singh, M. Robbins, Marianna Vinokur, J. Lee, Noah L Rosen
Although headache disorders have the secondhighest disease burden worldwide, the field remains vastly underserved. Access to care is limited by lack of certified specialists, geographic distribution of specialized care, financial restrictions, and overall burden of disease. People with headache disorders receive care largely from primary care, neurologists, and headache subspecialists. Assessments, evaluations, and treatments vary tremendously based upon training and experience. Until recently, medical school training in headache has been limited. Most subspecialist education occurred as apprenticeship at centers of excellence or was fostered by clinical practice and supported by continuing medical education. In 2003 the United Council for Neurologic Subspecialities (UCNS) was incorporated. The first accredited headache programs and certification examinations occurred in 2006. This required standardization of program expectations, a basic curriculum, and core content. Currently, there are 46 fellowships available throughout the United States. The American Headache Society (AHS) National Fellowship Opportunities website features the most uptodate information about the application cycle, individual program details, open positions, names of applicants who have filled positions, and program contact information. Participating programs must abide by the unified application timeline and match process; any program deemed noncompliant may be suspended from the website. The last several years have seen an increasingly organized headache fellowship matching process (Figure 1). The Consortium of Academic Headache Program Directors voted to pursue the match and the AHS Board of Directors signed an agreement with the National Resident Matching Program (NRMP) to sponsor the match in 2022 (timeline in Table 1). Immediately following the match, the
{"title":"Headache fellowship match shareholder insights","authors":"Skyler L Kanegi, Niushen Zhang, Cynthia E. Armand, Rashmi B Halker Singh, M. Robbins, Marianna Vinokur, J. Lee, Noah L Rosen","doi":"10.1111/head.14333","DOIUrl":"https://doi.org/10.1111/head.14333","url":null,"abstract":"Although headache disorders have the secondhighest disease burden worldwide, the field remains vastly underserved. Access to care is limited by lack of certified specialists, geographic distribution of specialized care, financial restrictions, and overall burden of disease. People with headache disorders receive care largely from primary care, neurologists, and headache subspecialists. Assessments, evaluations, and treatments vary tremendously based upon training and experience. Until recently, medical school training in headache has been limited. Most subspecialist education occurred as apprenticeship at centers of excellence or was fostered by clinical practice and supported by continuing medical education. In 2003 the United Council for Neurologic Subspecialities (UCNS) was incorporated. The first accredited headache programs and certification examinations occurred in 2006. This required standardization of program expectations, a basic curriculum, and core content. Currently, there are 46 fellowships available throughout the United States. The American Headache Society (AHS) National Fellowship Opportunities website features the most uptodate information about the application cycle, individual program details, open positions, names of applicants who have filled positions, and program contact information. Participating programs must abide by the unified application timeline and match process; any program deemed noncompliant may be suspended from the website. The last several years have seen an increasingly organized headache fellowship matching process (Figure 1). The Consortium of Academic Headache Program Directors voted to pursue the match and the AHS Board of Directors signed an agreement with the National Resident Matching Program (NRMP) to sponsor the match in 2022 (timeline in Table 1). Immediately following the match, the","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"37 1","pages":"766 - 769"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76471582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Worsening migraine: Another casualty of natural disasters","authors":"A. Gelfand, Rashmi B Halker Singh, M. Robbins","doi":"10.1111/head.14325","DOIUrl":"https://doi.org/10.1111/head.14325","url":null,"abstract":"","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"38 1","pages":"645 - 647"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87278213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. Richer, Samina Ali, David W Johnson, R. Rosychuk, A. Newton, B. Rowe
The objective of this study was to assess the efficacy and safety of a common monotherapy (intravenous [iv] metoclopramide) compared to a combination strategy (adding iv ketorolac to metoclopramide) in children presenting for acute treatment of migraine headache in the emergency department (ED).
{"title":"A randomized trial of ketorolac and metoclopramide for migraine in the emergency department","authors":"L. Richer, Samina Ali, David W Johnson, R. Rosychuk, A. Newton, B. Rowe","doi":"10.1111/head.14307","DOIUrl":"https://doi.org/10.1111/head.14307","url":null,"abstract":"The objective of this study was to assess the efficacy and safety of a common monotherapy (intravenous [iv] metoclopramide) compared to a combination strategy (adding iv ketorolac to metoclopramide) in children presenting for acute treatment of migraine headache in the emergency department (ED).","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"499 1","pages":"681 - 689"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75260321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Saldanha, W. Cao, M. R. Bhuma, K. Konnyu, G. Adam, A. Zullo, Kenneth K. Chen, Julie L Roth, E. Balk
{"title":"Systematic reviews can guide clinical practice and new research on primary headaches in pregnancy: An editorial on the 2022 American Headache Society Members' Choice Award paper","authors":"I. Saldanha, W. Cao, M. R. Bhuma, K. Konnyu, G. Adam, A. Zullo, Kenneth K. Chen, Julie L Roth, E. Balk","doi":"10.1111/head.14332","DOIUrl":"https://doi.org/10.1111/head.14332","url":null,"abstract":"","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"19 1","pages":"774 - 776"},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74402039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
No studies have evaluated the glymphatic system function in patients with migraine. In this pilot study, we evaluated and compared the alterations in the glymphatic system function in patients with migraine with healthy controls using a diffusion tensor imaging (DTI) analysis along the perivascular space (DTI‐ALPS) method. We also investigated the differences in the glymphatic system function table between patients with migraine with and without aura using the ALPS method.
{"title":"Normal glymphatic system function in patients with migraine: A pilot study","authors":"Dong Ah Lee, Ho-Joon Lee, K. Park","doi":"10.1111/head.14320","DOIUrl":"https://doi.org/10.1111/head.14320","url":null,"abstract":"No studies have evaluated the glymphatic system function in patients with migraine. In this pilot study, we evaluated and compared the alterations in the glymphatic system function in patients with migraine with healthy controls using a diffusion tensor imaging (DTI) analysis along the perivascular space (DTI‐ALPS) method. We also investigated the differences in the glymphatic system function table between patients with migraine with and without aura using the ALPS method.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"7 1","pages":"718 - 725"},"PeriodicalIF":0.0,"publicationDate":"2022-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84818816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Ezzati, K. Fanning, D. Buse, J. Pavlović, Cynthia E. Armand, M. Reed, V. Martin, R. Lipton
To identify predictors of acute treatment response for nonprescription (over‐the‐counter [OTC]) medications among people with migraine and develop improved models for predicting treatment response.
确定偏头痛患者非处方(非处方[OTC])药物急性治疗反应的预测因素，并开发预测治疗反应的改进模型。
{"title":"Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study","authors":"A. Ezzati, K. Fanning, D. Buse, J. Pavlović, Cynthia E. Armand, M. Reed, V. Martin, R. Lipton","doi":"10.1111/head.14312","DOIUrl":"https://doi.org/10.1111/head.14312","url":null,"abstract":"To identify predictors of acute treatment response for nonprescription (over‐the‐counter [OTC]) medications among people with migraine and develop improved models for predicting treatment response.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"33 1","pages":"755 - 765"},"PeriodicalIF":0.0,"publicationDate":"2022-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81053047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study deals with headache in relation to other major sequelae of traumatic brain injury (TBI) in veterans of Iraq and Afghanistan wars over 8 years after experiencing a deployment‐related TBI (DTBI).
{"title":"Persistence of headache and its relation to other major sequelae following traumatic brain injury at 2–8 years after deployment‐related traumatic brain injury in veterans of Afghanistan and Iraq wars","authors":"J. Couch, K. Stewart","doi":"10.1111/head.14303","DOIUrl":"https://doi.org/10.1111/head.14303","url":null,"abstract":"This study deals with headache in relation to other major sequelae of traumatic brain injury (TBI) in veterans of Iraq and Afghanistan wars over 8 years after experiencing a deployment‐related TBI (DTBI).","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"26 1","pages":"700 - 717"},"PeriodicalIF":0.0,"publicationDate":"2022-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74703481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zachary Leibovit-Reiben, R. Ishii, D. Dodick, Gina M. Dumkrieger, M. Cortez, K. Brennan, K. Digre, T. Schwedt
To investigate the impact of having headaches prior to traumatic brain injury (TBI) on headache features and long‐term patient health outcomes.
研究创伤性脑损伤(TBI)前头痛对头痛特征和患者长期健康结局的影响。
{"title":"The impact of pre‐morbid headaches on headache features and long‐term health outcomes following traumatic brain injury: Insights from the American Registry for Migraine Research","authors":"Zachary Leibovit-Reiben, R. Ishii, D. Dodick, Gina M. Dumkrieger, M. Cortez, K. Brennan, K. Digre, T. Schwedt","doi":"10.1111/head.14311","DOIUrl":"https://doi.org/10.1111/head.14311","url":null,"abstract":"To investigate the impact of having headaches prior to traumatic brain injury (TBI) on headache features and long‐term patient health outcomes.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"2 1","pages":"566 - 576"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79447257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tien-Wei Hsu, Mu-Hong Chen, Che-Sheng Chu, S. Tsai, Ya-Mei Bai, T. Su, Tzeng-Ji Chen, C. Liang
This study explored the risk of migraine in children, adolescents, and young adults with attention deficit hyperactivity disorder (ADHD) and its association with ADHD medications.
{"title":"Attention deficit hyperactivity disorder and risk of migraine: A nationwide longitudinal study","authors":"Tien-Wei Hsu, Mu-Hong Chen, Che-Sheng Chu, S. Tsai, Ya-Mei Bai, T. Su, Tzeng-Ji Chen, C. Liang","doi":"10.1111/head.14306","DOIUrl":"https://doi.org/10.1111/head.14306","url":null,"abstract":"This study explored the risk of migraine in children, adolescents, and young adults with attention deficit hyperactivity disorder (ADHD) and its association with ADHD medications.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"1 1","pages":"634 - 641"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87161447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alfredo Munoz, Christina R. Maxwell, Natalie Gofman, K. Liebman, E. Veznedaroglu
The objective of this paper is to present a narrative review of the use of triptans in the treatment of trigeminal neuralgia (TN), as well as to outline possible therapeutic mechanisms of action.
本文的目的是介绍使用曲坦类药物治疗三叉神经痛(TN)的叙述性回顾，以及概述可能的治疗机制的作用。
{"title":"The management of trigeminal neuralgia with triptans, a narrative review of the literature","authors":"Alfredo Munoz, Christina R. Maxwell, Natalie Gofman, K. Liebman, E. Veznedaroglu","doi":"10.1111/head.14321","DOIUrl":"https://doi.org/10.1111/head.14321","url":null,"abstract":"The objective of this paper is to present a narrative review of the use of triptans in the treatment of trigeminal neuralgia (TN), as well as to outline possible therapeutic mechanisms of action.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"191 1","pages":"543 - 547"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78054624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：